You need to enable JavaScript to run this app.
Recon: FDA Rejects Vanda’s Jet Lag Drug; Roche and AbbVie Price New Cancer, RA Drugs
Recon
Michael Mezher
ReconMichael Mezher
ReconMichael Mezher